Skip to main content
. 2019 Sep 4;9:12760. doi: 10.1038/s41598-019-49251-5

Table 2.

Previous therapies.

Characteristic N = 15
N (%)
Previous treatment for advanced disease
Number of treatment lines – Median (range) 2.5 (1–7)
Hormonal therapy 6 (40)
Trastuzumab 15 (100)
Capecitabine-lapatinib 12 (80)
Lyposomal Anthracyclines 2 (13.4)
Taxanes 7 (47)
Previous treatment for adjuvant/neoadjuvant therapy
Hormonal therapy 7 (47)
Trastuzumab 14 (94)
Anthracyclines 9 (60)
Taxanes 9 (60)
CMF 2 (13.4)
Carboplatin 1 (6.7)

CMF, Cyclophosphamide, Methotrexate, Fluorouracil.